Literature DB >> 22337828

Effects of amyloid-β plaque proximity on the axon initial segment of pyramidal cells.

Gonzalo León-Espinosa1, Javier DeFelipe, Alberto Muñoz.   

Abstract

The output of cortical pyramidal cells reflects the balance between excitatory inputs of cortical and subcortical origin, and inhibitory inputs from distinct populations of cortical GABAergic interneurons, each of which selectively innervate different domains of neuronal pyramidal cells (i.e., dendrites, soma and axon initial segment [AIS]). In Alzheimer's disease (AD), the presence of amyloid-β (Aβ) plaques alters the synaptic input to pyramidal cells in a number of ways. However, the effects of Aβ plaques on the AIS have still not been investigated to date. This neuronal domain is involved in input integration, as well as action potential initiation and propagation, and it exhibits Ca2+- and activity-dependent structural plasticity. The AIS is innervated by GABAergic axon terminals from chandelier cells, which are thought to exert a strong influence on pyramidal cell output. In the AβPP/PS1 transgenic mouse model of AD, we have investigated the effects of Aβ plaques on the morphological and neurochemical features of the AIS, including the cisternal organelle, using immunocytochemistry and confocal microscopy, as well as studying the innervation of the AIS by chandelier cell axon terminals. There is a strong reduction in GABAergic terminals that appose AIS membrane surfaces that are in contact with Aβ plaques, indicating altered inhibitory synapsis at the AIS. Thus, despite a lack of gross structural alterations in the AIS, this decrease in GABAergic innervation may deregulate AIS activity and contribute to the hyperactivity of neurons in contact with Aβ plaques.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22337828     DOI: 10.3233/JAD-2012-112036

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  8 in total

1.  Remodeling of the axon initial segment after focal cortical and white matter stroke.

Authors:  Jason D Hinman; Matthew N Rasband; S Thomas Carmichael
Journal:  Stroke       Date:  2012-12-11       Impact factor: 7.914

2.  Amyloid-β plaques disrupt axon initial segments.

Authors:  Miguel A Marin; Jokubus Ziburkus; Joanna Jankowsky; Matthew N Rasband
Journal:  Exp Neurol       Date:  2016-04-21       Impact factor: 5.330

3.  Pyramidal cell axon initial segment in Alzheimer´s disease.

Authors:  Alejandro Antón-Fernández; Gonzalo León-Espinosa; Javier DeFelipe; Alberto Muñoz
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

4.  Oxidative Stress Induces Disruption of the Axon Initial Segment.

Authors:  Kareem Clark; Brooke A Sword; Jeffrey L Dupree
Journal:  ASN Neuro       Date:  2017 Nov-Dec       Impact factor: 4.146

5.  Area-specific alterations of synaptic plasticity in the 5XFAD mouse model of Alzheimer's disease: dissociation between somatosensory cortex and hippocampus.

Authors:  Nadine Crouzin; Kevin Baranger; Mélanie Cavalier; Yannick Marchalant; Catherine Cohen-Solal; François S Roman; Michel Khrestchatisky; Santiago Rivera; François Féron; Michel Vignes
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

Review 6.  Defining the earliest pathological changes of Alzheimer's disease.

Authors:  James C Vickers; Stan Mitew; Adele Woodhouse; Carmen M Fernandez-Martos; Mathew T Kirkcaldie; Alison J Canty; Graeme H McCormack; Anna E King
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

Review 7.  Relevance of 5-HT2A Receptor Modulation of Pyramidal Cell Excitability for Dementia-Related Psychosis: Implications for Pharmacotherapy.

Authors:  Ethan S Burstein
Journal:  CNS Drugs       Date:  2021-07-05       Impact factor: 5.749

8.  Synapse-specific expression of calcium-permeable AMPA receptors in neocortical layer 5.

Authors:  Txomin Lalanne; Julia Oyrer; Adamo Mancino; Erica Gregor; Andrew Chung; Louis Huynh; Sasha Burwell; Jérôme Maheux; Mark Farrant; P Jesper Sjöström
Journal:  J Physiol       Date:  2015-12-17       Impact factor: 5.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.